Chrissy Metz Weight Loss | GLP-1 Reveal, Ro Partnership, Broadway Debut & Health Bio

Chrissy Metz’s weight loss has drawn fresh attention after the This Is Us star revealed that she is now using a GLP-1 medication after years of skepticism. Metz, 45, says the decision was driven less by appearance than by her health, perimenopause, family history of obesity, and a desire to feel stronger while performing on Broadway. Her partnership with telehealth company Ro has also put a new spotlight on her experience, with Ro stating that Metz has lost 63 pounds while using GLP-1s.

The update marks another turn in a health journey Metz has discussed openly for years. As she performs as Angélique in Broadway’s & Juliet, she says reduced food noise, inflammation, and joint discomfort have helped her feel more mobile and energetic. But Metz has been equally clear that medication is only one part of the picture: she continues strength training, works with a trainer, and says she is more interested in feeling healthy and capable than reaching a specific number on the scale.

Chrissy Metz Reveals GLP-1 Weight Loss Journey After Years of Skepticism

Chrissy Metz is opening up about a major shift in the way she approaches weight management after years of feeling skeptical about GLP-1 medications. GLP-1 medications mimic hormones involved in appetite and blood-sugar regulation; certain drugs in this class are approved for chronic weight management. The actress recently shared that she is using a GLP-1 medication as part of a broader effort to prioritize her long-term health, particularly as she navigates perimenopause and considers her family history of obesity. She says the changes she has experienced since starting treatment have also helped with the physical demands of performing in Broadway’s & Juliet. Her decision marks a personal change for Metz, who has been candid about her relationship with weight and body image throughout her career.

Metz is now a paid partner of telehealth company Ro, which provides access to GLP-1 weight-management treatment and related clinical support. Metz has not centered her own comments around reaching a specific goal weight, however, and has instead emphasized improvements such as reduced food noise, better mobility, less joint discomfort, and feeling stronger.

Metz has stressed that GLP-1 medication is not a “magic wand” or instant solution. Instead, she views it as one tool alongside lifestyle changes, saying she has experienced less inflammation and joint discomfort as well as a noticeable reduction in persistent “food noise.” 

Metz’s current GLP-1 treatment is only one part of a much longer health journey. Years earlier, she lost 100 pounds after changing her eating habits and incorporating regular walking, well before publicly revealing her GLP-1 use in 2026.

Inside Chrissy Metz’s Partnership with Ro and Perimenopause Health Update

At 45, Metz says navigating perimenopause and thinking more seriously about longevity helped change her perspective on GLP-1 medication. She has explained that the physical changes that come with midlife encouraged her to rethink some of the weight-management methods she had tried in the past. Rather than focusing only on losing weight, Metz now wants to feel stronger, healthier, and better equipped for the years ahead.

Her family health history has also influenced that decision. After watching her father experience health problems and considering the history of obesity in her family, Metz says she became more determined to take a proactive approach to her own health. Her goals extend beyond appearance, with a focus on maintaining her mobility, strength, and overall health as she gets older. At the same time, Metz is currently making her Broadway debut as Angélique in & Juliet. She stepped into the role on June 16, 2026, and is scheduled to continue her limited engagement through September 13.

Through Ro, Metz has access to GLP-1 treatment and clinical support, while she says she is also continuing lifestyle changes such as strength training and working with a trainer.

If you love deep dives into massive streaming sensations, check out our breakdown of the “Unsettling!” Watch Robert Pattinson’s Shocking Transformation as Chris Hansen in A24’s ‘Primetime’ Trailer

How Chrissy Metz Says GLP-1 Treatment Has Helped Her Mobility on Broadway

Chrissy Metz says the health changes she has experienced since starting GLP-1 treatment have helped with the physical demands of Broadway. While playing Angélique in & Juliet, she performs on an eight-show-a-week schedule, and she says reduced inflammation and joint discomfort have made moving onstage more comfortable.

Her increased stamina has also become important as she takes on the fast pace of & Juliet. The musical combines live singing with constant movement, energetic numbers, and demanding choreography, requiring performers to maintain their energy from one scene to the next. For Metz, feeling stronger and more mobile has helped her keep up with the rhythm of the production without allowing physical discomfort to overshadow her performance.

Beyond the immediate benefits, Metz is also focused on maintaining her strength and mobility for the long term. She works with a trainer and incorporates weight training into her routine, which complements her broader approach to health and helps her build and maintain muscle. Rather than viewing weight loss as the only measure of progress, Metz has emphasized feeling stronger, moving more comfortably, and supporting her body through the demands of both Broadway and everyday life.

Chrissy Metz Responds to Criticism Over Her GLP-1 Weight Loss

Chrissy Metz is making it clear that her health choices are hers to make, despite the criticism that often comes with discussing weight loss in the public eye. After revealing her partnership with Ro and her decision to use a GLP-1 medication, the This Is Us star addressed the reactions surrounding her changing approach to weight management. Rather than allowing outside opinions to dictate her decisions, Metz has emphasized that she knows her own body, health history, and personal circumstances better than anyone watching from the sidelines.

Metz has also pointed to the contradictory scrutiny surrounding her weight. She recalled that people previously asked why she was not using a GLP-1, while she expects some of those same observers to question her now that she has chosen to try one. Metz's response is straightforward: she doesn't expect everyone to agree with her decision. She says the people criticizing her don't have access to her medical history or conversations with her doctors, so she is making the choice based on what she believes is best for her health.

Read More: Stay updated with our latest features in the Entertainment Category

Metz says she has learned to tune out negative comments and focus instead on conversations with her doctors and people she trusts. Her willingness to reconsider a treatment she once doubted also reflects how her priorities have changed as she thinks more about longevity, strength, and her family health history.

For More News, Entertainment, Follow CelebWikiCorner.